Bausch + Lomb Corporation (BLCO) Receives a Hold from Stifel Nicolaus

Stifel Nicolaus analyst Thomas Stephan maintained a Hold rating on Bausch + Lomb Corporation today and set a price target of $16.00.

Meet Samuel – Your Personal Investing Prophet

• Start a conversation with TipRanks’ trusted, data-backed investment intelligence
• Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds

Stephan covers the Healthcare sector, focusing on stocks such as TransMedics Group, Alphatec Holdings, and Alcon. According to TipRanks, Stephan has an average return of 5.6% and a 40.66% success rate on recommended stocks.

Bausch + Lomb Corporation has an analyst consensus of Moderate Buy, with a price target consensus of $18.67.

Based on Bausch + Lomb Corporation’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $1.24 billion and a GAAP net loss of $71 million. In comparison, last year the company earned a revenue of $1.14 billion and had a GAAP net loss of $212 million

Based on the recent corporate insider activity of 70 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of BLCO in relation to earlier this year. Most recently, in March 2026, Sam Eldessouky, the EVP & CFO of BLCO bought 4,000.00 shares for a total of $68,520.00.